AFT Pharmaceuticals: Improving Profitability
Edison | Mar 29, 2018 02:38AM ET
AFT Pharmaceuticals Ltd (AX:AFP) recently announced an agreement with Baxter Healthcare to divest to Baxter some of its non-core and low-margin hospital products in New Zealand. An agreement for similar products is expected in Australia in the coming weeks. Once both are complete, the company expects the divestments to represent approximately 7.5% of operating revenue (likely between NZ$5m and NZ$6m). The divestments are expected to generate NZ$5m in cash and make a positive contribution of “several million dollars” to EBITDA. Whatever is lost in revenues is likely to be made up in higher overall gross margin, and lower sales and marketing expenses.
Increasing focus on Maxigesic
With the divestment of some of its hospital products in Australia and New Zealand, AFT will be achieving two things: it will improve its overall profitability and generate cash to fund its plans for Maxigesic across the globe which, if successful, would be transformative for the company.
To read the entire report Please click on the pdf File Below:
Get The News You Want
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.